News Sentiment

PROF sentiment intelligence

Profound Medical Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 60 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 7.04 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 60

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+3.4% over one week, +6.3% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Profound Medical Corp.

Market Reaction

Balanced read

66/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction 3.4% Price confirming higher
Trend fit Trend inactive 6.3% over four weeks
Fair value -5.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 21
Neutral 37
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 60
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 20
TradingView 5
Stock Titan 5
Stock Traders Daily 4
TradingKey 3
Simply Wall Street 3
Investing News Network 3
dars.gov.et 2

Event Lens

What the news is about

Classified themes
Market update 32
Earnings 24
Guidance 2
Analyst action 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 60
Stock Titan Direct company coverage

[EFFECT] Profound Medical Corp. SEC Filing

Profound Medical Corp. (NASDAQ: PROF) has announced an SEC Filing for Form EFFECT, indicating the effectiveness of its S-3 Shelf Registration Statement as of May 19, 2026, at 4:30 P.M. The filing shows a neutral impact and sentiment according to Rhea-AI. Profound Medical Corp. ha

Tone
Neutral 50/100
Event
Market update
Published
20 May 2026 10:35
Source
Stock Titan
The Globe and Mail Direct company coverage

Profound Medical Shareholders Back Board, Question Incentive Plan

Profound Medical Corp. shareholders re-elected their existing board of directors with strong majorities and reappointed PricewaterhouseCoopers LLP as auditors. However, a significant 36% opposition was noted for the approval of unallocated restricted and deferred share units unde

Tone
Neutral 50/100
Event
Regulatory and legal
Published
17 May 2026 10:11
Source
The Globe and Mail
TradingView Direct company coverage

Profound Medical Annual General and Special Meeting of Shareholders Voting Results

Profound Medical Corp. announced the voting results from its Annual General and Special Meeting of Shareholders, where all eight director nominees were elected and the appointment of PricewaterhouseCoopers LLP as auditor was approved. Shareholders also approved unallocated restri

Tone
Neutral 50/100
Event
Earnings
Published
15 May 2026 23:40
Source
TradingView
Stock Titan Direct company coverage

Profound Medical (NASDAQ: PROF) investors back board, auditor and long‑term incentive units

Profound Medical Corp. (NASDAQ: PROF) shareholders approved the election of eight directors, the reappointment of PricewaterhouseCoopers LLP as auditors with 99.497% support, and confirmed all unallocated restricted and deferred share units under its long-term incentive plan. The

Tone
Positive 61/100
Event
Market update
Published
15 May 2026 20:09
Source
Stock Titan
Stock Traders Daily Direct company coverage

How Profound Medical Corp. (PROF) Affects Rotational Strategy Timing

Profound Medical Corp. (PROF) shows neutral near-term sentiment but strong mid and long-term strength, with support being tested. The company has an exceptional 74.0:1 risk-reward setup, targeting a 21.0% gain against 0.3% risk. AI models have generated distinct trading strategie

Tone
Positive 75/100
Event
Market update
Published
15 May 2026 05:52
Source
Stock Traders Daily
TipRanks Direct company coverage

Profound Medical Highlights TULSA Advances at AUA 2026

Profound Medical's TULSA Procedure will be a focal point at AUA2026 with four presentations detailing its safety, efficacy, and functional outcomes in treating localized prostate cancer. The company plans to integrate PSMA PET imaging with its TULSA-PRO platform to improve treatm

Tone
Neutral 50/100
Event
Market update
Published
14 May 2026 23:39
Source
TipRanks
Stock Titan Direct company coverage

Profound Medical (NASDAQ: PROF) to highlight TULSA and PSMA PET integration at AUA2026

Profound Medical Corp. announced plans to showcase its MRI-guided TULSA Procedure™ at the American Urological Association's 2026 Annual Meeting, featuring four oral presentations and demonstrations of TULSA-PRO®. The company also unveiled an initiative to integrate PSMA PET molec

Tone
Positive 70/100
Event
Market update
Published
14 May 2026 20:39
Source
Stock Titan
The Manila Times Direct company coverage

Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) announced that its TULSA Procedure™ will be highlighted in four oral presentations at the upcoming American Urological Association’s (AUA) Annual Meeting. The company will also showcase its TULSA-PRO® and an actual Siemens MAGNETOM Fr

Tone
Positive 86/100
Event
Market update
Published
14 May 2026 11:39
Source
The Manila Times
Focused Ultrasound Foundation Direct company coverage

Company Profile: Profound Medical

Tone
Neutral 50/100
Event
Market update
Published
21 Mar 2018 07:00
Source
Focused Ultrasound Foundation